Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices

The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights.

The Wall Street Journal | Dirección, Legal | Administración Pública, Farmacia |

Leer noticia completa en el medio original
Spanish